IL293776B1 - Methods for treating parkinson's disease - Google Patents
Methods for treating parkinson's diseaseInfo
- Publication number
- IL293776B1 IL293776B1 IL293776A IL29377622A IL293776B1 IL 293776 B1 IL293776 B1 IL 293776B1 IL 293776 A IL293776 A IL 293776A IL 29377622 A IL29377622 A IL 29377622A IL 293776 B1 IL293776 B1 IL 293776B1
- Authority
- IL
- Israel
- Prior art keywords
- disease
- methods
- treating parkinson
- parkinson
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01015—Glutamate decarboxylase (4.1.1.15)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962947418P | 2019-12-12 | 2019-12-12 | |
| PCT/US2020/064928 WO2021119615A1 (en) | 2019-12-12 | 2020-12-14 | Methods for treating parkinson's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL293776A IL293776A (en) | 2022-08-01 |
| IL293776B1 true IL293776B1 (en) | 2026-07-01 |
Family
ID=76330812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL293776A IL293776B1 (en) | 2019-12-12 | 2020-12-14 | Methods for treating parkinson's disease |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230050187A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4072568A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7758671B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220114028A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020403266A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022011584A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3161322A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL293776B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022007193A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021119615A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026085129A1 (en) * | 2024-10-15 | 2026-04-23 | MeiraGTx Neuro I, LLC | High-dose gad gene therapy for treating parkinson's disease |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001089583A2 (en) * | 2000-05-23 | 2001-11-29 | Neurologix, Inc. | Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases |
| US20050025746A1 (en) * | 2000-05-23 | 2005-02-03 | Neurologix, Inc. | Glutamic acid decarboxylase (GAD) based delivery systems |
| WO2018232055A1 (en) * | 2017-06-15 | 2018-12-20 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030087264A1 (en) * | 2001-05-22 | 2003-05-08 | Kaplitt Michael G. | Transcriptional regulation of target genes |
| EP1893754A4 (en) * | 2005-05-31 | 2009-01-21 | Neurologix Inc | NEW GLUTAMIC ACID DECARBOXYLASE (GAD) CHIMESES AND USE PROCESSES |
-
2020
- 2020-12-14 CA CA3161322A patent/CA3161322A1/en active Pending
- 2020-12-14 MX MX2022007193A patent/MX2022007193A/es unknown
- 2020-12-14 EP EP20898391.6A patent/EP4072568A4/en active Pending
- 2020-12-14 BR BR112022011584A patent/BR112022011584A2/pt unknown
- 2020-12-14 JP JP2022535694A patent/JP7758671B2/ja active Active
- 2020-12-14 IL IL293776A patent/IL293776B1/en unknown
- 2020-12-14 AU AU2020403266A patent/AU2020403266A1/en active Pending
- 2020-12-14 KR KR1020227023752A patent/KR20220114028A/ko active Pending
- 2020-12-14 US US17/784,510 patent/US20230050187A1/en active Pending
- 2020-12-14 WO PCT/US2020/064928 patent/WO2021119615A1/en not_active Ceased
-
2025
- 2025-10-09 JP JP2025171111A patent/JP2025188191A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001089583A2 (en) * | 2000-05-23 | 2001-11-29 | Neurologix, Inc. | Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases |
| US20050025746A1 (en) * | 2000-05-23 | 2005-02-03 | Neurologix, Inc. | Glutamic acid decarboxylase (GAD) based delivery systems |
| WO2018232055A1 (en) * | 2017-06-15 | 2018-12-20 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
Non-Patent Citations (4)
| Title |
|---|
| ALLEN PATRICIA J ET AL:, GENE-BASED THERAPIES IN PARKINSON'S DIS, 16 October 2013 (2013-10-16) * |
| KAPLITT ET AL.:, SAFETY AND TOLERABILITY OF GENE THERAPY WITH AN ADENO-ASSOCIATED VIRUS (AAV) BORNE GAD GENE FOR PARKINSON'S DISEASE: AN OPEN LABEL, PHASE I TRIAL, 21 June 2007 (2007-06-21) * |
| LUO JIA ET AL:, SUBTHALAMIC GAD GENE THERAPY IN A PARKINSON'S DISEASE RAT MODEL, 11 October 2002 (2002-10-11) * |
| NIETHAMMER MARTIN ET AL:, LONG-TERM FOLLOW-UP OF A RANDOMIZED AAV2-GAD GENE THERAPY TRIAL FOR PARKINSON'S DISEASE, 6 April 2017 (2017-04-06) * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220114028A (ko) | 2022-08-17 |
| US20230050187A1 (en) | 2023-02-16 |
| EP4072568A1 (en) | 2022-10-19 |
| EP4072568A4 (en) | 2024-02-07 |
| JP7758671B2 (ja) | 2025-10-22 |
| MX2022007193A (es) | 2022-09-19 |
| BR112022011584A2 (pt) | 2022-12-13 |
| JP2023506007A (ja) | 2023-02-14 |
| WO2021119615A1 (en) | 2021-06-17 |
| AU2020403266A1 (en) | 2022-08-04 |
| CA3161322A1 (en) | 2021-06-17 |
| JP2025188191A (ja) | 2025-12-25 |
| IL293776A (en) | 2022-08-01 |